Summary

● Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

● The company has a good ESG score relative to its sector, according to Refinitiv.


Strengths

● The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.

● The stock, which is currently worth 2024 to 0.24 times its sales, is clearly overvalued in comparison with peers.

● The company appears to be poorly valued given its net asset value.

● The company has a low valuation given the cash flows generated by its activity.

● The company is one of the best yield companies with high dividend expectations.


Weaknesses

● According to forecast, a sluggish sales growth is expected for the next fiscal years.

● The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.

● As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.

● Low profitability weakens the company.

● For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.

● For the past year, analysts have significantly revised downwards their profit estimates.

● The average consensus view of analysts covering the stock has deteriorated over the past four months.

● Over the past twelve months, analysts' consensus has been significantly revised downwards.